Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: Effects on blood pressure, endocrine function, sodium and plasma volume M. GrimmP. WeidmannW. H. Ziegler Originals Pages: 79 - 84
Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication P. J. NeuvonenE. ElonenM. Laakso Originals Pages: 85 - 89
Pharmacokinetic studies in man of the selective beta1-adrenoceptor agonist, prenalterol C. GraffnerK. -J. HoffmannO. Rönn Originals Pages: 91 - 97
Codeine-induced memory changes: Nature and relationship to opiate system R. Liljequist Originals Pages: 99 - 107
Clinical trial of a modified inhaler for pressurized aerosols K. -G. HidingerJ. Perk Originals Pages: 109 - 111
Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man A. SardiM. P. VettaroV. Tamassia Originals Pages: 113 - 118
Control of antibiotic therapy in paediatric patients N. PrincipiP. MarchisioF. Sereni Originals Pages: 119 - 121
Excretion of paracetamol in human breast milk P. -O. BitzénB. GustafssonE. Wåhlin-Boll Originals Pages: 123 - 125
Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay R. A. UptonR. L. WilliamsS. Riegelman Originals Pages: 127 - 133
Pharmacokinetics of zimelidine in humans — Plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine B. L. LoveR. G. MooreS. Chaturvedi Originals Pages: 135 - 139
Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose W. A. C. McAllisterC. R. WinfieldJ. V. Collins Originals Pages: 141 - 145
Disposition of azapropazone in chronic renal and hepatic failure K. -H. BreuingH. -J. GilfrichE. Jähnchen Originals Pages: 147 - 155
